Literature DB >> 85870

Adrenal suppression after short-term corticosteroid therapy.

R J Spiegel, R A Vigersky, A I Oliff, C K Echelberger, J Bruton, D G Poplack.   

Abstract

Adrenal function was evaluated in fourteen cancer patients receiving chemotherapy which included short-term high-dose courses of prednisone. 90 min corticotropin stimulation tests were performed before therapy and 1, 2, 4, and 7 days after steroids were discontinued. Responses were evaluated by standard criteria of adrenal function and by measurement of the intergrated cortisol response to corticotropin over 90 min. Thirteen of fourteen patients had suppressed adrenal function for at least 24 h. Although in most patients adrenal function had returned to normal between day 2 and 4, in five patients it remained suppressed for 7 days or more. Suppression did not correlate with either steroid dose or duration of therapy. Four of five patients receiving only 5 days' therapy showed evidence of adrenal suppression. Although overt clinical adrenal insufficiency after steroid administration is rare, these results indicate that adrenal function is suppressed more regularly after short-term high-dose steroid therapy than has been appreciated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85870     DOI: 10.1016/s0140-6736(79)91077-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Efficacy of methylprednisolone in controlling complications after impacted lower third molar surgical extraction.

Authors:  J M Micó-Llorens; M Satorres-Nieto; J Gargallo-Albiol; J Arnabat-Domínguez; L Berini-Aytés; C Gay-Escoda
Journal:  Eur J Clin Pharmacol       Date:  2006-08-11       Impact factor: 2.953

Review 2.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Recovery of the hypothalamus-pituitary-adrenal axis after short term high dose corticosteroid treatment in neurosurgical practice.

Authors:  P Hedner; G Kullberg; I Bostedt
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

Review 4.  Drug withdrawal syndromes-- a literature review.

Authors:  G C Hodding; M Jann; I P Ackerman
Journal:  West J Med       Date:  1980-11

Review 5.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

6.  A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients.

Authors:  Hye-Suk Han; Young Kwang Shim; Jeong Eun Kim; Hyun-Jung Jeon; Sung-Nam Lim; Tae-Keun Oh; Ki Hyeong Lee; Seung Taik Kim
Journal:  Support Care Cancer       Date:  2011-08-18       Impact factor: 3.603

7.  Corticosteroid therapy and intercurrent illness: the need for continuing patient education.

Authors:  S R Peacey; R M Pope; K S Naik; R D Hardern; M D Page; P E Belchetz
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

8.  A pharmacological and clinical comparison of prednisolone and betamethasone in rheumatoid arthritis.

Authors:  R J Marwah; M E Pickup; H Al-Shakarchi; J S Dixon; J R Lowe; H A Bird; V Wright
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone.

Authors:  R Collomp; Z Labsy; H Zorgati; F Prieur; F Cottin; M C Do; O Gagey; F Lasne; K Collomp
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

10.  Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.

Authors:  J Webb; T J Clark
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.